Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
Primary Purpose
Chronic Liver Disease
Status
Completed
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Nutritional Supplement
Standard Nutritional Treatment
Sponsored by

About this trial
This is an interventional treatment trial for Chronic Liver Disease
Eligibility Criteria
Inclusion Criteria:
- Nutritional intervention in children with moderate and severe malnutrition as pr standard anthropometric measures children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed : 3mo to 3 yrs) with infantile cholestasis syndrome)
- Hindi/English speaking family
Exclusion Criteria:
- Any metabolic or endocrinal diseases independently affecting nutritional status
- Refusal to give written informed consent to participate in the study
Sites / Locations
- Institute of liver and Biliary Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Nutritional Supplement
Standard nutritional treatment
Arm Description
Diet Counseling (Energy=200 kcal/kg/day, (present weight) protein =3-4 gm/kg/day) Nutritional supplement (Providing extra 40 kcal/kg/day)
Diet counselling only (Energy=200 kcal/kg/day (present weight) protein =3-4 gm/kg/day). Standard nutritional treatment
Outcomes
Primary Outcome Measures
To study the effect of special fortified indigenous diet on growth,and outcome in children with infantile cholestasis syndrome
Growth is a composite outcome defines as age and sex appropriate anthropometric measures- weight , height, mid arm circumference, triceps skin fold thickness, subscapular skin fold thickness.
To study the effect of special fortified indigenous diet on hepatic morbidity in children with infantile cholestasis syndrome
hepatic morbidity is a composite outcome comprising of ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, intercurrent infections, variceal bleed.
To study the effect of special fortified indigenous diet on outcome in children with infantile cholestasis syndrome
Outcome is defined as survival with native liver, death or liver transplantation
Secondary Outcome Measures
To study the levels of IL-6 before & after nutritional therapy in malnourished children with Chronic Liver Disease
Full Information
NCT ID
NCT02715973
First Posted
February 17, 2016
Last Updated
December 4, 2018
Sponsor
Institute of Liver and Biliary Sciences, India
1. Study Identification
Unique Protocol Identification Number
NCT02715973
Brief Title
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
Official Title
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
October 31, 2017 (Actual)
Study Completion Date
October 31, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Liver and Biliary Sciences, India
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed 3mo to 3 yrs) with infantile cholestasis syndrome will be randomized to either recieve indigenously prepared oral nutritional supplement (energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician (Group A). The control group (Group B) in comparison will receive standard nutritional counseling from a trained dietician but will not receive any additional nutritional supplement. All the children will be followed up at 1 month, 3 months, 6 months, 9 months and 1 year after inclusion. Clinical, nutritional assessment and laboratory data will be collected at each visit. Additionally IL-6 levels will be done at each visit in children of both arms of the intervention group.
The outcomes of interest will be growth and improvement of nutritional status parameters, hepatic morbidity (ascites, gastrointestinal bleeding, encephalopathy, {SBP (Spontaneous Bacterial Peritonitis), HRS (Hepatorenal Syndrome), etc and outcome (improvement, death or Liver Transplantation}.
All children will receive individualized standard treatment for infantile cholestasis syndrome including vitamin supplements/endotherapy/ beta blockers/ prophylaxis for SBP (Spontaneous Bacterial Peritonitis)/cholangitis (to at risk children) and drug therapy wherever indicated (steroids/ copper chelation/ UDCA).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Liver Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nutritional Supplement
Arm Type
Experimental
Arm Description
Diet Counseling (Energy=200 kcal/kg/day, (present weight) protein =3-4 gm/kg/day)
Nutritional supplement (Providing extra 40 kcal/kg/day)
Arm Title
Standard nutritional treatment
Arm Type
Active Comparator
Arm Description
Diet counselling only (Energy=200 kcal/kg/day (present weight) protein =3-4 gm/kg/day).
Standard nutritional treatment
Intervention Type
Dietary Supplement
Intervention Name(s)
Nutritional Supplement
Intervention Description
Energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age.
Intervention Type
Dietary Supplement
Intervention Name(s)
Standard Nutritional Treatment
Intervention Description
Standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age
Primary Outcome Measure Information:
Title
To study the effect of special fortified indigenous diet on growth,and outcome in children with infantile cholestasis syndrome
Description
Growth is a composite outcome defines as age and sex appropriate anthropometric measures- weight , height, mid arm circumference, triceps skin fold thickness, subscapular skin fold thickness.
Time Frame
1 year
Title
To study the effect of special fortified indigenous diet on hepatic morbidity in children with infantile cholestasis syndrome
Description
hepatic morbidity is a composite outcome comprising of ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, intercurrent infections, variceal bleed.
Time Frame
1 year
Title
To study the effect of special fortified indigenous diet on outcome in children with infantile cholestasis syndrome
Description
Outcome is defined as survival with native liver, death or liver transplantation
Time Frame
1 year
Secondary Outcome Measure Information:
Title
To study the levels of IL-6 before & after nutritional therapy in malnourished children with Chronic Liver Disease
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
3 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Nutritional intervention in children with moderate and severe malnutrition as pr standard anthropometric measures children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed : 3mo to 3 yrs) with infantile cholestasis syndrome)
Hindi/English speaking family
Exclusion Criteria:
Any metabolic or endocrinal diseases independently affecting nutritional status
Refusal to give written informed consent to participate in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr Seema Alam, MD
Organizational Affiliation
Institute of Liver and Biliary Sciences
Official's Role
Study Director
Facility Information:
Facility Name
Institute of liver and Biliary Sciences
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110070
Country
India
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
We'll reach out to this number within 24 hrs